 OncoSec Medical Incorporated Nasdaq:ONCS the Company or OncoSec, a company developing late-stage intratumoral cancer immunotherapies, today announced the appointment of Herbert Kim Lyerly, M.D., George Barth Geller Professor, Professor of Immunology, Surgery and Pathology 